StockData
Scienture Holdings, Inc. logo

Scienture Holdings, Inc. (SCNX) stock

SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$2.28−0.16 (-6.45%)

Close on Nov 20, 2026Market cap $4.07MP/E –Yield –

Scienture gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Scienture's gross profit for the twelve months ending Sep 30, 2026 was $1.17M, up 101.6% year over year. For fiscal 2025 it was $331.48K, up 5420.1% from the year before. Over ten years it grew -19.0% a year on average. The highest annual figure on record is $5.71M in fiscal 2020.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$331.48K+5420.1%
FY2024Dec 31, 2024$6.01K-87.8%
FY2023Dec 31, 2023$49.03K-99.1%
FY2022Dec 31, 2022$5.52M+16.3%
FY2021Dec 31, 2021$4.75M-16.8%
FY2020Dec 31, 2020$5.71M+17.2%
FY2019Dec 31, 2019$4.87M+44.0%
FY2018Dec 31, 2018$3.38M+15.4%
FY2017Dec 31, 2017$2.93M+18.1%
FY2016Dec 31, 2016$2.48M-8.8%
FY2015Dec 31, 2015$2.72M+157.8%
FY2014Dec 31, 2014$1.06M+8842.3%
FY2013Dec 31, 2013$11.81K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.02M+77.5%
Q2 FY2026Jun 30, 2026$335.78K–
Q1 FY2026Mar 31, 2026$53.85K+7901.5%
Q4 FY2025Dec 31, 2025-$243.81K-8730.5%
Q3 FY2025Sep 30, 2025$574.62K+14698.4%
Q2 FY2025Jun 30, 2025$0–
Q1 FY2025Mar 31, 2025$673–
Q4 FY2024Dec 31, 2024$2.83K-92.9%
Q3 FY2024Sep 30, 2024$3.88K-94.2%
Q2 FY2024Jun 30, 2024-$703-101.0%
Q4 FY2023Dec 31, 2023-$113.96K-107.5%
Q3 FY2023Sep 30, 2023$39.59K-97.1%
Q2 FY2023Jun 30, 2023$67.14K-94.3%
Q1 FY2023Mar 31, 2023$73.22K-94.5%
Q4 FY2022Dec 31, 2022$1.52M+22.3%
Q3 FY2022Sep 30, 2022$1.37M+7.1%
Q2 FY2022Jun 30, 2022$1.17M+39.2%
Q1 FY2022Mar 31, 2022$1.34M-3.4%
Q4 FY2021Dec 31, 2021$1.24M+831.7%
Q3 FY2021Sep 30, 2021$1.28M-33.6%
Q2 FY2021Jun 30, 2021$841.39K-58.0%
Q1 FY2021Mar 31, 2021$1.38M-15.7%
Q4 FY2020Dec 31, 2020$133.11K-89.4%
Q3 FY2020Sep 30, 2020$1.93M+47.2%
Q2 FY2020Jun 30, 2020$2.00M+72.3%
Q1 FY2020Mar 31, 2020$1.64M+43.0%
Q4 FY2019Dec 31, 2019$1.25M+47.6%
Q3 FY2019Sep 30, 2019$1.31M+55.1%
Q2 FY2019Jun 30, 2019$1.16M+38.9%
Q1 FY2019Mar 31, 2019$1.15M+34.4%
Q4 FY2018Dec 31, 2018$846.99K+7.2%
Q3 FY2018Sep 30, 2018$845.13K+14.8%
Q2 FY2018Jun 30, 2018$837.69K+18.9%
Q1 FY2018Mar 31, 2018$852.92K+14.3%
Q4 FY2017Dec 31, 2017$789.74K+20.7%
Q3 FY2017Sep 30, 2017$735.87K–
Q2 FY2017Jun 30, 2017$704.73K–
Q1 FY2017Mar 31, 2017$745.94K–
Q4 FY2016Dec 31, 2016$654.39K–

More Scienture figures

See a number that looks wrong?